back to top
HomeTagsAlzheimerx27s

Alzheimerx27s

New Medical Information Demonstrates Three Years of Steady Therapy with Twin-Appearing LEQEMBI (lecanemab-irmb) Continues to Considerably Profit Early Alzheimer's Illness Sufferers Offered at AAI...

TOKYO and CAMBRIDGE, Mass., Jul 31, 2024 - (JCN Newswire) - - Eisai Co (OTC:)., Ltd. and Biogen Inc (NASDAQ:). introduced at this time...

InMed experiences progress in Alzheimer's drug research By Investing.com

VANCOUVER - InMed Prescription drugs Inc. (NASDAQ: INM), a developer of small molecule drug candidates for illnesses with unmet medical wants, right now introduced...

Most Popular

spot_img